Overall, we identified MYH7 as a novel diagnostic marker with a high diagnostic accuracy for PAs, and MYH7 may be associated with a tumor-suppressive microenvironment through promoting the exhaustion of immune cells. Here, MYH7 is linked to neoplasm.